Lepetegravir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lepetegravir, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed [Phase 2, Phase 3]